Niigata University Medical ＆ Dental Hospital

Niigata, Niigata 951-8520

3 studies enrolling now · 9 studies all time

What they study most

ALS, Alopecia Areata, Alzheimers Disease, Alzheimers Disease, Familial, Amyotrophic Lateral Sclerosis, Aortic Aneurysm, Thoracic, Chronic Cutaneous Lupus Erythematosus, Dementia, Penetrating Ulcer, Primary Membranous Nephropathy, Severe Alopecia Areata, Subacute Cutaneous Lupus Erythematosus

Studies at this site

• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) — Recruiting now
• Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib — Recruiting now
• A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Enrolling by invitation
• A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Running, not enrolling
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 — Running, not enrolling
• A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata — Running, not enrolling
• Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers — Running, not enrolling
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early